SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-000459
Filing Date
2021-01-07
Accepted
2021-01-07 16:31:02
Documents
1
Period of Report
2021-01-04
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 34875
  Complete submission text file 0001493152-21-000459.txt   36081
Mailing Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501
Business Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38519 | Film No.: 21514546
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences